Callan Family Office’s Stryker SYK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.44M Buy
10,922
+1,804
+20% +$568K 0.07% 256
2026
Q1
$3M Sell
9,118
-451
-5% -$162K 0.07% 272
2025
Q4
$3.36M Buy
9,569
+1,419
+17% +$517K 0.07% 247
2025
Q3
$3.01M Sell
8,150
-642
-7% -$248K 0.1% 216
2025
Q2
$3.48M Buy
8,792
+4,655
+113% +$1.74M 0.11% 199
2025
Q1
$1.54M Sell
4,137
-269
-6% -$102K 0.12% 157
2024
Q4
$1.59M Buy
+4,406
New +$1.63M 0.1% 174

Other funds holding SYK

Callan Family Office's SYK Position: Q2 2026 in Review

Callan Family Office increased its Stryker (SYK) stake by 20% in Q2 2026, buying an estimated $568K and bringing the position to 10,922 shares worth $3.44M. The position accounts for 0.07% of the portfolio, ranked #256.

Callan Family Office first reported a position in SYK in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.48M in Q2 2025. 2,267 funds tracked by Wall St. Rank hold SYK as of Q2 2026.

  • Callan Family Office held 10,922 shares of Stryker worth $3.44M as of Q2 2026.
  • Callan Family Office bought 1,804 Stryker shares in Q2 2026, an estimated $568K.
  • Stryker made up 0.07% of Callan Family Office's portfolio in Q2 2026, its #256 holding.
  • Callan Family Office first reported a position in Stryker in Q4 2024 and has held it in 7 quarters since.
  • Callan Family Office's Stryker position peaked at $3.48M in Q2 2025.
  • 2,267 funds tracked by Wall St. Rank held Stryker as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.